據報螞蟻集團完成股東結構調整 無直接或間接股東單一或共同控制
據天眼查App顯示,螞蟻集團第一大股東杭州君瀚股權投資合夥企業發生工商變更,杭州雲鉑投資諮詢有限公司退出合夥人及執行事務合夥人,新增杭州星滔企業管理諮詢有限公司為合夥人及執行事務合夥人。目前,該合夥企業由杭州君潔股權投資合夥企業、杭州星滔企業管理諮詢有限公司、馬雲、謝世煌共同出資。
螞蟻集團早前發布公告,為進一步適應現代公司治理體系的要求,推動股東投票權與其經濟利益相匹配,螞蟻集團主要股東及相關受益人擬對螞蟻集團股東上層結構進行調整。調整後,螞蟻集團各主要股東彼此獨立行使股份表決權且無一致行動關係,不再存在任何直接或間接股東單一或共同控制螞蟻集團的情形。(ca/u)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.